Proteome Sciences (LON:PRM) Reaches New 52-Week Low – What’s Next?

Proteome Sciences plc (LON:PRM)’s share price reached a new 52-week low during trading on Thursday. The company traded as low as GBX 1.10 and last traded at GBX 1.10, with a volume of 194,816 shares traded. The stock had previously closed at GBX 1.43.

Proteome Sciences Stock Down 22.9%

The company has a current ratio of 0.12, a quick ratio of 0.37 and a debt-to-equity ratio of -161.07. The firm has a market capitalization of £3.86 million, a price-to-earnings ratio of -1.53 and a beta of 0.16. The firm has a 50 day moving average price of GBX 1.45 and a two-hundred day moving average price of GBX 1.62.

Proteome Sciences (LON:PRM) last posted its earnings results on Wednesday, September 16th. The company reported GBX (0.41) earnings per share for the quarter. Proteome Sciences had a negative net margin of 61.46% and a positive return on equity of 23.85%.

About Proteome Sciences

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.